How were Alere's earnings last quarter?

Alere Inc. (NYSE:ALR) announced its quarterly earnings results on Friday, November, 4th. The medical research company reported $0.19 earnings per share for the quarter, missing the consensus estimate of $0.54 by $0.35. The medical research company had revenue of $582 million for the quarter, compared to the consensus estimate of $605.50 million. Alere had a negative net margin of 5.34% and a negative trailing twelve-month return on equity of 20.78%. Alere's revenue was down 3.6% on a year-over-year basis. During the same period last year, the business earned ($0.10) EPS.

What other stocks do shareholders of Alere own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Alere investors own include Morgan Stanley (MS) , BioTelemetry (BEAT) , Abbott Laboratories (ABT) , FireEye (FEYE) , Twitter (TWTR) , Allergan (AGN) , AEGR (AEGR) , Ashmore Group (ASHM) , Chembio Diagnostics (CEMI) and Capitala Finance (CPTA) .

NYSE:ALR

Alere (ALR) Stock Price, News & Analysis

→ Secret Bull Market Starts in This Unusual Sector (From Altimetry) (Ad)

Free ALR Stock Alerts

Notice: This company has been marked as potentially delisted and may not be actively trading.

Compare

Today's Range: $1.32
▼
$1.32
50-Day Range: N/A
52-Week Range: $34.41
▼
$51.00

Volume: N/A
Average Volume: 40,839 shs
Market Capitalization: $43.05 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get Alere alerts:

Ad Altimetry

Secret Bull Market Starts in This Unusual Sector

"We're only at the very beginning of a new wave that could deliver 500%-plus gains in the years to come." In fact, 50 small companies related to this sector have already soared 100% or more in a recent 90-day stretch.

Click for my No. 1 investment, all free of charge, click here.

About Alere Stock (NYSE:ALR)

Alere Inc. is a provider of health information through diagnostic tests. The Company's segments include professional diagnostics, consumer diagnostics, and corporate and other. The professional diagnostics segment includes an array of diagnostic test products and other in vitro diagnostic tests marketed to medical professionals and laboratories for detection of diseases and conditions within its areas of focus. The consumer diagnostics segment consists primarily of manufacturing operations related to its role as the exclusive manufacturer of products for SPD Swiss Precision Diagnostics (SPD), its joint venture with The Procter & Gamble Company (P&G). The Company's professional diagnostic solutions allow patients and their healthcare providers to work together to manage patients' conditions over the continuum of care, from the hospital to home. The Company offers lines of drugs-of-abuse tests, reagent systems and laboratory testing options.

Ad Altimetry

Secret Bull Market Starts in This Unusual Sector

Click for my No. 1 investment, all free of charge, click here.

ALR Stock News Headlines

April 11, 2024 | businesswire.com

AlerisLife and Five Star Senior Living Awarded Great Place to Work® Certification

December 28, 2023 | morningstar.com

Alro SA ALR

April 19, 2024 | Crypto 101 Media (Ad)

SHOCKING Crypto Leak…

A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.

April 18, 2023 | thestreet.com

Alere (ALR) Stock Plummets, Rejects Abbott's Request to End Merger

April 9, 2023 | yahoo.com

Trek's latest aluminium Émonda ALR is lighter and racier than before

February 3, 2023 | finance.yahoo.com

ABP Acquisition to Acquire AlerisLife for $1.31 Per Share

November 2, 2022 | finance.yahoo.com

AlerisLife Inc. Announces Third Quarter 2022 Results

October 17, 2022 | finance.yahoo.com

AlerisLife Announces the Appointment of Philip Benjamson as a Senior Vice President and Chief Operating Officer

April 19, 2024 | Crypto 101 Media (Ad)

SHOCKING Crypto Leak…

October 16, 2022 | seekingalpha.com

Abbott Q3 Earnings Preview: I'm Still Not A Buyer (NYSE:ABT) - Seeking Alpha

October 11, 2022 | prnewswire.com

Critical Care Diagnostics Market to Exceed US$ 1.7 Billion by 2031 Amid Rising Prevalence of Chronic Diseases - PR Newswire

October 11, 2022 | prnewswire.com

Drug Screening Market is expected to generate a revenue of USD 22.16 Billion by 2030, Globally, at 10.6% CAGR: Verified Market Research® - PR Newswire

October 7, 2022 | benzinga.com

At 5.4% CAGR, Arbovirus Testing Market Size is Expected to Reach US$ 1919.7 Mn by 2030 | Market Expected - Benzinga

October 5, 2022 | benzinga.com

Outlook on the Isothermal Nucleic Acid Amplification Technology Global Market to 2030 - Featuring Alere, - Benzinga

October 5, 2022 | finance.yahoo.com

AlerisLife Inc. Third Quarter 2022 Conference Call Scheduled for Thursday, November 3rd

October 5, 2022 | finance.yahoo.com

Global Infectious Disease In Vitro Diagnostics Market Report (2022 to 2030) - High Demand for PoC Facilities is Driving Growth - Yahoo Finance

October 5, 2022 | globenewswire.com

Outlook on the Isothermal Nucleic Acid Amplification Technology Global Market to 2030 - Featuring Alere, Biomerieux and Lucigen Among Others - GlobeNewswire

September 19, 2022 | finance.yahoo.com

AlerisLife Announces the Appointment of Heather Pereira as Senior Vice President, Chief Financial Officer and Treasurer

September 9, 2022 | finance.yahoo.com

AlerisLife Inc. (ALR)

August 13, 2022 | investing.com

ALR_pb Historical Data

August 6, 2022 | finance.yahoo.com

AlerisLife (NASDAQ:ALR) adds US$18m to market cap in the past 7 days, though investors from five years ago are still down 89%

August 3, 2022 | nasdaq.com

Alere Inc. Q2 Loss decreases, but misses estimates

August 3, 2022 | finance.yahoo.com

AlerisLife Inc. Announces Second Quarter 2022 Results

July 22, 2022 | reuters.com

Column: Aluminium producers feel the margin pain as price slumps

July 6, 2022 | finance.yahoo.com

AlerisLife Inc. Second Quarter 2022 Conference Call Scheduled for Thursday, August 4th

June 28, 2022 | finance.yahoo.com

AlerisLife Provides a Business Update

June 14, 2022 | streetinsider.com

Mainz Biomed Appoints Vice President of Clinical Affairs to Lead US Clinical Studies in Support of FDA Submission - StreetInsider.com

See More Headlines

Receive ALR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Alere and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 11/04/2016
Today: 4/19/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NYSE
Sector: Medical
Industry: Skilled nursing care facilities
Sub-Industry: Health Care Supplies
Current Symbol: NYSE:ALR
CUSIP: 01449J10
CIK: 1145460
Web: www.alere.com
Phone: +1-781-6473900
Fax: 617-796-8385
Employees: 10,400
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): ($1.20)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-29,920,000.00
Net Margins: -5.34%
Pretax Margin: -5.29%
Return on Equity: -20.78%
Return on Assets: -9.02%

Debt

Debt-to-Equity Ratio: 0.45
Current Ratio: 1.58
Quick Ratio: 1.58

Sales & Book Value

Annual Sales: $934.59 million
Price / Sales: 0.05
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $5.72 per share
Price / Book: 0.23

Miscellaneous

Outstanding Shares: 32,610,000
Free Float: 29,870,000
Market Cap: $43.05 million
Optionable: Optionable
Beta: 0.85

10 Best Stocks to Own in 2024

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

Key Executives

Gregg J. Powers
Independent Chairman of the Board
Namal Nawana
President, Chief Executive Officer, Director
James F. Hinrichs
Chief Financial Officer, Executive Vice President
Daniella Cramp
Global President - Cardiometabolic Business Unit
Sanjay Malkani
Global President - Toxicology
Avi Pelossof
Global President - Infectious Disease Business Unit
Ellen Chiniara J.D.
Senior Vice President, General Counsel, Chief Ethics and Compliance Officer, Secretary
Robert Hargadon
Senior Vice President - Global Human Resources
John Bridgen Ph.D.
Senior Vice President - Business Development
Mark Gladwell
Senior Vice President - Global Operations

Key Competitors

View All Competitors

ALR Stock Analysis - Frequently Asked Questions

How were Alere's earnings last quarter?: Alere Inc. (NYSE:ALR) announced its quarterly earnings results on Friday, November, 4th. The medical research company reported $0.19 earnings per share for the quarter, missing the consensus estimate of $0.54 by $0.35. The medical research company had revenue of $582 million for the quarter, compared to the consensus estimate of $605.50 million. Alere had a negative net margin of 5.34% and a negative trailing twelve-month return on equity of 20.78%. Alere's revenue was down 3.6% on a year-over-year basis. During the same period last year, the business earned ($0.10) EPS.
What other stocks do shareholders of Alere own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Alere investors own include Morgan Stanley (MS), BioTelemetry (BEAT), Abbott Laboratories (ABT), FireEye (FEYE), Twitter (TWTR), Allergan (AGN), AEGR (AEGR), Ashmore Group (ASHM), Chembio Diagnostics (CEMI) and Capitala Finance (CPTA).

This page (NYSE:ALR) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Alere (ALR) Stock Price, News & Analysis

About Alere Stock (NYSE:ALR)

ALR Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

ALR Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info